The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.

Recruiting now

Conditions studied: Melanoma of Skin

In brief

Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage. The biosamples are collected in the BioBank Dresden and used for the NMR and LC-MS analyses described here. It is planned to use the biosamples for further analyses.

Key facts

Study ID

NCT06765850

Run by

Technische Universität Dresden

People needed

3000

Starts

2022-07-04

Expected to finish

2027-06-01

Last updated by the study team

2025-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current or past history of melanoma
• Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital

You may not qualify if…

• Refusal to participate in the study
• Lack of capacity to consent

Where it is running

• University Hospital Carl Gustav Carus — Dresden, Saxony, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.